Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1987 Mar;146(3):351–352.

Neurology

Immunotherapy in Multiple Sclerosis

Jack C Sipe
PMCID: PMC1307285  PMID: 18750168

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Durelli L., Cocito D., Riccio A., Barile C., Bergamasco B., Baggio G. F., Perla F., Delsedime M., Gusmaroli G., Bergamini L. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology. 1986 Feb;36(2):238–243. doi: 10.1212/wnl.36.2.238. [DOI] [PubMed] [Google Scholar]
  2. McFarlin D. E. Use of interferon in multiple sclerosis. Ann Neurol. 1985 Oct;18(4):432–433. doi: 10.1002/ana.410180403. [DOI] [PubMed] [Google Scholar]
  3. Scheinberg L. C., Van den Noort S. Editorial on multiple sclerosis treatments. Neurology. 1986 May;36(5):703–704. doi: 10.1212/wnl.36.5.703. [DOI] [PubMed] [Google Scholar]
  4. Weiner H. L., Hauser S. L., Hafler D. A., Fallis R. J., Lehrich J. R., Dawson D. M. The use of cyclophosphamide in the treatment of multiple sclerosis. Ann N Y Acad Sci. 1984;436:373–381. doi: 10.1111/j.1749-6632.1984.tb14808.x. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES